Pathogenetic justification and clinical significance of using arginine for prevention of critical ischemia of lower extremities and fatal manifestations of multifocal atherosclerosis
Journal Title: Серце і судини - Year 2018, Vol 0, Issue 4
Abstract
The aim — to investigate the results of treatment with L‑arginine of patients with intermittent claudication for prevention of critical stages of limb ischemia. Materials and methods. 86 patients with intermittent claudication were randomly divided into two groups of 43 patients each. Patients of the first group received 8 g of L‑arginine (Tivortin) twice a day, patients of the second group — 40 mg of prostaglandin E1 (PGE1) twice a day. Results and discussion. Administration of L‑arginine contributed to an increase in the distance of painless walk by 230 ± 63 %, the absolute walk distance — by 155 ± 48 % (p < 0.05), the administration of PGE1 — by 209 ± 63 % and 144 ± 28 %, respectively (p < 0.05). Treatment with L‑arginine increased the value of the coefficient of L‑arginine/asymmetric dimethylarginine in plasma and the excretion of nitrates and cGMP in the urine, which indicated the normalization of the biosynthesis of endogenous NO. PGE1 therapy did not significantly affect endothelium‑dependent vasodilation parameters. The coefficient of quality of life, estimated in an analog scale, increased from 3.51 ± 0.18 to 8.3 ± 0.4 in the arginine group and to 7.0 ± 0.5 in the PGE1 group (all p < 0.05). Conclusions. Arginine is a drug of choice to prevention of severe forms of lower limbs ischemia and other manifestations of multifocal atherosclerosis.
Authors and Affiliations
V. G. Mishalov, V. A. Chernyak, O. I. Sopko, D. Ye. Dubenko
Keywords
Related Articles
- EP ID EP451377
- DOI 10.30978/HV2018-4-79
- Views 134
- Downloads 0
Endometrioma of the rectus abdominis
Endometriosis is determined if the endometrial tissue is located outside the uterine cavity. Endometrial tissue can be localized in the peritoneum, vagina, scar tissue, cervix, fallopian tubes, rectum, urinary tract, Dou...
Methods of treating patients with non‑restructuring chronic critical lower limb ischemia using autologous mesenchymal stem cells
The prevalence of peripheral arteries disease (PAD) ranges from 3 to 10 % in the general population, reaching 15 — 20 % in subjects older than 70 years. PDA affects 27 million people in Europe and the USA. The annual num...
Living activities limitation of population of Ukraine due to chronic venous diseases of lower limbs
The aim — to analyze the level and structure of primary (PD) and accumulated disability (AD) due to chronic venous diseases of the lower extremities (CVDLE) over the past five years in Ukraine. Materials and methods. T...
Clinical characterіstics and survival of hospitalized patients with chronic heart failure and reduced left ventricular ejection fraction depending on dynamics of nitrogen-releasing kidney function during period of overcoming clinical decompensation
The aim — to investigate the main clinical hemodynamic and laboratory characteristics in hospitalized patients with chronic heart failure (CHF), depending on the dynamics of the nitrogen‑releasing renal function during t...
Acute myocardial infarction in patients with diabetes mellitus: possibility and expediency of cardioprotection
The aim — to evaluate the efficacy and safety of addition of a solution containing 4.2 g of arginine hydrochloride and 2.0 g L‑carnitine to standard therapy of patients with acute coronary syndrome (ACS) with ST segment...